Abstract
The development of vaccines has been one of the most important endeavors in the fight to counter and control infectious diseases. Vaccination is based on the activation of a protective immune response to the infectious agent by immunogenic antigens of the pathogenic microorganism. Most microorganisms are not pathogenic but are indeed beneficial and can enrich our lives. Some species or strains among the microorganisms in the categories including viruses, bacteria, fungi, and protozoa can, however, produce disease. The processes by which such microorganisms cause infectious diseases are not in many cases completely understood. GeneraIly, these organisms must be able to either colonize or invade the tissues and to cause damage. In this respect, many disease-causing microorganisms produce toxins, which are poisonous products of their metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
DiRita, V.J. (1994) Multiple regulatory systems inVibrio choleraepathogenesisTrends Microbiol. 237–38.
Straley, S.C. and Perry, R.D. (1995) Environmental modulation of gene expression and pathogenesis inYersinia Trends Microbiol. 3310–317.
Leclerc, C., and Ronco, J. (1998) New approaches in vaccine developmentImmunol. Today 19300–302.
Hess, J., and Kaufmann, S.H.E. (1996) Neue Strategien in der Impfstoff-EntwicklungBiospektrum 418–23.
Kuby, J. (1997) Immunology, Third Edition, W.H. Freeman and Company, New York.
Abbas, A.K., Lichtman, A.H., Pober, J.S. (1997)Cellular and Molecular ImmunologyThird Edition, W.B. Saunders Company, Philadelphia.
Pearce, E.J., Caspar, P., Grzych, J.-M., Lewis, F.A., and Sher, A. (1991) Downregulation of Thl cytokine production accompanies induction of Th2 responses by a parasitic helminthShistosoma mansoni J. Exp. Med.173, 159–166.
Marinaro, M., Staats, H.F., Hiroi, T., Jackson, R.J., Coste, M., Boyaka, P.N., Okahashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K., and McGhee, J.R. (1995) Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4,.I.Immunol.155, 4621–4629.
VanCott, J.L., Staats, H.F., Pascual, D.W., Roberts, M., Chatfield, S.N., Yamamoto, M., Coste, M., Carter, P.B., Kiyono, H., and McGhee, J.R. (1996) Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinantSalmonella J. Immunol.156, 1504–1514.
Bona, C.A., Casares, S., and Brumeanu, T.-D. (1998) Towards development of T-cell vaccinesImmunol. Today19, 126–133.
Liew, F.Y. (1988) Biotechnological trends towards synthetic vaccinesImmunol. Lett.19, 241–244.
Chattergoon, M., Boyer, J., and Weiner, D.B. (1997) Genetic immunization: a new era in vaccines and immune therapeuticsFASEB J.11, 753–763.
Tighe, H., Corr, M., Roman, M., and Raz, E. (1998) Gene vaccination: plasmid DNA is more than just a blueprintImmunol. Today19, 89–97.
Ulmer, J.B., Donnelly, J.J., and Liu, M.A. (1996) DNA vaccines promising: a new approach to inducing protective immunityASM News62, 476–479.
Young, P. (1997) Bright outlook on direct DNA immunizationsASM News63, 659–663.
Stephenne, A. (1988) Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectivenessVaccine6, 299–303.
Welkos, S.L., and Friedlander, A.M. (1988) Comparative safety and efficacy againstBacillus anthracisof protective antigen and live vaccines in m iceMicrob. Pathog.5, 127–139.
Tzschaschel, B.D., Guzman, C., Timmis, K.N., and de Lorenzo, V. (1996) AnEscherichia colihemolysin transport system-based vector for the export of polypeptides: Export of Shiga-like toxin IIeB subunit bySalmonella typhimuriumaroANature Biotechnol.14, 765–769.
Van Regenmortel, M. (1997) Searching for safer, more potent, better-targeted adjuvantsASM News63, 136–139.
Kissel, T., Koneberg, R., Hilbert, A.K., and Hungerer, K.-D. (1997) Micro-encapsulation of antigens using biodegradable polyesters: facts and phantasiesBehring Institute Mitteilungen 98172–183.
Hancock, R.E.W., and Wong, R. (1997) Potential of protein OprF ofPseudomonasin bivalent vaccinesBehring Institute Mitteilungen 98283–290.
Fischetti, V.A. (1996) Gram-positive commensal bacteria deliver antigens to elicit mucosal and systemic immunityASM News 62405–410.
Medaglini, D., Pozzi, G., King, T.P., and Fischetti, V.A. (1995) Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacteriumStreptococcus gordoniiafter oral immunization.Proc. Natl. Acad. Sci. USA 926868–6872.
Bundesamt für Zivilschutz.(1975)Zivilschutz. Gefahren aus der Retorte. Gesundheitliche Aspekte bei chemischen und biologischen KampfinittelBand 6, BZS-Schriftenreihe, Weltgesundheitsorganisation (WHO), Mönch, Bonn].
Cong, Y., Weaver, C.T., and Elson, C.O. (1997) The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expressionI. Immunol. 1595301–5308.
Medina, E., Talay, S.R., Chhatwal, G.S., and Guzman, C.A. (1998) Fibronectin-binding protein I ofStreptococcus pyogenes isa promising adjuvant for antigens delivered by mucosal routeEur. Immunol. 281069–1077.
Moss, B. (1985) Vaccinia virus expression vector: a new tool for immunologistsImmunol. Today 6243–245.
Perkus, M.E., Piccini, A., Lipinskas, B.R., and Paoletti, E. (1985) Recombinant vaccinia virus: immunization against multiple pathogensScience 229981–984.
Restifo, N.P. (1996) The new vaccines: building viruses that elicit antitumor immunityCurrent Opin. Immunol. 8658–663.
Morsy, M.A., and Caskey, C.T. (1997) Safe gene vectors made simplerNature Biotechnol. 1517.
Kochanek, S., Clemens, P.R., Mitani, K., Chen, H.-H., Chan, S., and Caskey, C.T. (1996) A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and (3-galactosidaseProc. Natl. Acad Sci. USA 935731–5736.
Carter, B.J. (1996) The promise of adeno-associated virus vectorsNature Biotechnol. 141725–1725.
Berglund, P., Tubulekas, I., and Liljeström, P. (1996) Alphaviruses as vectors for gene deliveryTrends Biotechnol. 14130–134.
Strauss, J.H., and Strauss, E. (1994) The alphaviruses: gene expression, replication, and evolutionMicrobiol. Rev. 58491–562.
Rolph, M.S., and Ramshaw, I.A. (1997) Recombinant viruses as vaccines and immunological toolsCurrent Opin. Immunol. 9517–524.
Thomson, S.A., Elliott, S.L., Sherritt, M.A., Sproat, K.W., Coupar, B.E.H., Scalzo, A.A., Forbes, C.A:; Ladhams, A.M., Mo, X.Y., Tripp, R.A., Doherty, P.C., Moss, D.J., and Suhrbier, A. (1996) Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesJ. Immunol. 157822–826.
An, L., and Whitton, J.L. (1997) A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen, J.Virol. 712292–2302.
Dougan, G., Chatfield, S., Pickard, D., Bester, J., O’Callaghan, D., and Maskell, D. (1988) Construction and characterization of vaccine strains ofSalmonellaharboring mutations in two differentarogenes, J.Infect. Dis. 1581329–1335.
Levine, M.M., Galen, J., Barry, E., Noriega, F., Tacket, C., Sztcin, M., Chatfield, S., Dougan, G., Losonsky, G., and Kotloff, K. (1997) AttenuatedSalmonella typhiandShigellaas live oral vaccines and as live vectorsBehring Institute Mitteilungen 98120–123.
Steidler, L., Robinson, K., Chamberlain, L., Schofeld, K.M., Remaut, E., Le Page, R.W.F., and Wells, J.M. (1998) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains ofLactococcus lactisco-expressing antigen and cytokineInfect. Immun. 663183–3189.
Sirard, J.-C., Fayolle, C., de Chastellier, C., Mock, M., Leclerc, C., and Berche, P. (1997) Intracytoplasmic delivery of Listeriolysin O by a vaccinal strain ofBacillus anthracisinduces CD8-mediated protection againstListeria monocytogenes. I Immunol. 1594435–4443.
Fox, J. (1997) Taking multiple paths toward mucosal immunityASM News 63413–414.
Ulmer, J.B., Sadoff, J.C., and Liu, M.A. (1996) DNA vaccinesCurr. Opin. Immunol. 8531–536.
Thomson, S.A., Sherritt, M.A., Medveczky, J., Elliott, S.L., Moss, D.J., Fernando, G.J.P., Brown, L.E., and Suhrbier, A. (1998) Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccinationI. Immunol. 1601717–1723.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nixdorff, K. (2001). Possibilities and Limitations of Vaccination. In: Kelle, A., Dando, M.R., Nixdorff, K. (eds) The Role of Biotechnology in Countering BTW Agents. NATO Science Series, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0775-7_14
Download citation
DOI: https://doi.org/10.1007/978-94-010-0775-7_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6906-6
Online ISBN: 978-94-010-0775-7
eBook Packages: Springer Book Archive